Travere Therapeutics Inc (NASDAQ: TVTX) is 36.15% higher on its value in year-to-date trading and has touched a low of $5.12 and a high of $14.62 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TVTX stock was last observed hovering at around $12.84 in the last trading session, with the day’s loss setting it -0.6%.
Currently trading at $12.24, the stock is 28.03% and 30.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.32 million and changing -4.67% at the moment leaves the stock 51.78% off its SMA200. TVTX registered -11.82% loss for a year compared to 6-month gain of 57.94%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 39.89% loss in the last 1 month and extending the period to 3 months gives it a 73.13%, and is 21.79% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.45% over the week and 6.36% over the month.
Travere Therapeutics Inc (TVTX) has around 380 employees, a market worth around $936.24M and $177.64M in sales. Profit margin for the company is -209.36%. Distance from 52-week low is 139.06% and -16.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-90.01%).
The EPS is expected to shrink by -132.12% this year
The shares outstanding are 76.49M, and float is at 75.75M with Short Float at 12.27%.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.64 million shares valued at $62.84 million. The investor’s holdings represent 9.8642 of the TVTX Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 7.5 million shares valued at $61.65 million to account for 9.6774 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 7.37 million shares representing 9.5096 and valued at over $60.58 million, while VANGUARD GROUP INC holds 8.5416 of the shares totaling 6.62 million with a market value of $54.41 million.
Travere Therapeutics Inc (TVTX) Insider Activity
Travere Therapeutics Inc disclosed in a document filed with the SEC on Sep 10 ’24 that Inrig Jula (CHIEF MEDICAL OFFICER) sold a total of 684 shares of the company’s common stock. The trade occurred on Sep 10 ’24 and was made at $12.98 per share for $8878.0. Following the transaction, the insider now directly holds 61949.0 shares of the TVTX stock.
Still, SEC filings show that on Sep 09 ’24, ROTE WILLIAM E. (SENIOR VICE PRESIDENT, R&D) disposed off 4,387 shares at an average price of $11.52 for $50538.0. The insider now directly holds 84,455 shares of Travere Therapeutics Inc (TVTX).
